Isophane Protamine Recombinant Human Insulin biosimilar (Popular Pharmaceuticals)
精蛋白重组人胰岛素生物类似药 (Popular Pharmaceuticals)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameIsophane Protamine Recombinant Human Insulin biosimilar (Popular Pharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2013/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPopular Pharmaceuticals Plc
China Registration ClassN/A
Develop Information
Active CompaniesPopular Pharmaceuticals Plc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code +[5]
Related LinksN/A